Counsel to CG Oncology for common stock offering valued up to $500M
CG Oncology engaged legal counsel for an Offering of Shares pursuant to an Open Market Sale Agreement. As a biopharma developer of drugs for urothelial cancer, successful capital raising is crucial for growth.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day